Latest news
Ensoma sheds more staff, pauses preclinical programs to home in on lead gene therapy - fiercebiotech.comfiercebiotech.com · Fri, 07 Aug 2026 15:16:34 GMTThe Oral GLP-1 Tracker: Lilly's Foundayo builds scripts after disappointing Q2 - Fierce PharmaFierce Pharma · Fri, 07 Aug 2026 14:55:51 GMTNovo Nordisk’s CFO on the oral Wegovy rollout and beyond - fiercebiotech.comfiercebiotech.com · Fri, 07 Aug 2026 12:42:20 GMTFierce Pharma Asia—Takeda’s historic narcolepsy nod; Daiichi’s accounting error; Astellas’ revenue beat - Fierce PharmaFierce Pharma · Fri, 07 Aug 2026 12:35:10 GMTVerilyMe, Bausch + Lomb visualize dry eye education in new collaboration - Fierce PharmaFierce Pharma · Fri, 07 Aug 2026 01:35:43 GMTTakeda gains FDA nod for first-in-class narcolepsy treatment Orzeyful - Fierce PharmaFierce Pharma · Thu, 06 Aug 2026 15:10:41 GMTDouble shot of Vistagen’s anxiety nasal spray misses in ph. 2 - fiercebiotech.comfiercebiotech.com · Thu, 06 Aug 2026 14:32:35 GMTTarsus pays $450M for Alkeus and its ph. 3 retinal disease drug - fiercebiotech.comfiercebiotech.com · Thu, 06 Aug 2026 14:30:00 GMT